Platinum-sensitive Ovarian Cancer (UPGRADE-A)
1 clinical trials · Condition
◉ Watch Platinum-sensitive Ovarian Cancer (UPGRADE-A)
| Record | Firm | Date |
|---|---|---|
| Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer (NCT04907968) | Mersana Therapeutics | 2021-06-11 |
Track Platinum-sensitive Ovarian Cancer (UPGRADE-A) automatically
Every clearance here is in the API, with alerts when new ones post.